China NMPA Drug Inspection - Xian Lijun Pharmaceutical Co., Ltd - Compound Glycyrrhiza Tablets
China NMPA drug inspection for Xian Lijun Pharmaceutical Co., Ltd published January 24, 2017. Drug: Compound Glycyrrhiza Tablets. The Shaanxi Provincial Food and Drug Administration issued an announcement on January 24, 2017, detailing results from i
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Xian Lijun Pharmaceutical Co., Ltd published January 24, 2017. Drug: Compound Glycyrrhiza Tablets. The Shaanxi Provincial Food and Drug Administration issued an announcement on January 24, 2017, detailing results from i
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox